Medicine and Dentistry
Liver Cirrhosis
100%
Portal Vein Thrombosis
93%
Hemostat
78%
Fibrinolysis
67%
Von Willebrand Factor
60%
Liver Disease
59%
Hepatic Portal Vein
49%
Blood Stasis
47%
Euglobulin Lysis Test
41%
Acute Liver Failure
37%
Thrombus
32%
Observational Study
29%
Prospective Study
29%
Fibrosis
29%
Consultation
29%
Prospective Cohort Study
29%
Von Willebrand Factor Cleaving Proteinase
29%
Outpatient
29%
Anticoagulant
26%
Bleeding
25%
Hepatic Vein
22%
Antithrombotic
22%
Systemic Circulation
17%
Fibrinogen
15%
Tissue Plasminogen Activator
14%
Hepatobiliary Surgery
14%
Thrombin
14%
Portal Hypertension
14%
Platelet
14%
Disease
10%
Portal Vein Blood Flow
9%
Chronic Liver Disease
8%
Liver Transplantation
7%
Blood Product
7%
Blood Clotting
7%
Thromboplastin
7%
Rivaroxaban
7%
Anti-Inflammatory Drug
7%
Thrombocyte Release Reaction
7%
Dabigatran
7%
Blood Clotting Inhibitor
7%
Procoagulant
7%
Acute on Chronic Liver Failure
7%
Prothrombin Time
7%
Partial Thromboplastin Time
7%
Laboratory Test
7%
Multiple Organ Dysfunction Syndrome
7%
Liver Injury
7%
Hypocoagulability
7%
Ischemia
7%
Keyphrases
Shared Decision Making
52%
Portal Vein
44%
Decision-making Behavior
44%
Decision-making Process
43%
Von Willebrand Factor
36%
Coagulation
35%
Hypercoagulability
33%
Portal Vein Thrombosis
33%
Bleeding
32%
Cirrhosis
32%
Fibrinolysis
29%
ADAMTS13
29%
Acute Liver Failure
29%
Portal Thrombosis
29%
Prospective Cohort Study
29%
Decision-making Styles
29%
Advanced Liver Disease
29%
Portal Vein Thrombus
29%
Vascular Bed
29%
Opening Statement
29%
Hospital Consultants
29%
Family Members
29%
Participatory Decision-making
29%
Older Patients
29%
Hepatic Vein
19%
Systemic Circulation
15%
Factor Level
14%
Patient Participation
14%
Hemostasis
12%
Liquid Permeation
11%
Thrombin Generation
11%
Clot Lysis
11%
Non-tumoral Portal Vein Thrombosis
11%
Anticoagulant Pathways
9%
Ischemia Progression
9%
Liver
9%
Inflammation
8%
Patients with Liver Disease
8%
Chronic Liver Disease
8%
Acute Liver Injury
7%
Hypofibrinolysis
7%
Bleeding Patients
7%
Hospital Outpatient Clinics
7%
Multilevel Analysis
7%
Consultation Duration
7%
Teaching Hospital
7%
Sectional Analysis
7%
Secondary Care
7%
Control Preferences Scale
7%
Netherlands
7%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
44%
Von Willebrand Factor
44%
Acute Liver Failure
37%
Blood Stasis
33%
Inflammation
33%
Von Willebrand Factor Cleaving Proteinase
29%
Fibrinolytic Agent
29%
Liver Disease
29%
Bleeding
22%
Tissue Plasminogen Activator
19%
Hemostatic Agent
18%
Thromboplastin
14%
Thrombin
14%
Clotting Time
9%
Enoxaparin
9%
Dabigatran
9%
Rivaroxaban
9%
Anti-Inflammatory Drug
7%
Ischemia
7%
Disease
7%
Fibrinogen
7%
Procoagulant
7%
Blood Clotting Inhibitor
7%
Prothrombin
7%
Multiple Organ Failure
7%
Liver Injury
7%
Hypocoagulability
7%
Acute on Chronic Liver Failure
7%
Liver Cirrhosis
7%